Early convalescent plasma may lower risk of severe COVID in seniorsMary Van Beusekom | News Writer | CIDRAP NewsJan 06, 2021Only 16% of those treated developed severe disease, compared with 31% in the placebo group.https://www.cidrap.umn.edu/news/178636/rss Share on Facebook Tweet Now Follow us Share Share Share Share Share Share this:TwitterFacebookLike this:Like Loading...Related Post navigationEuropean officials OK Moderna vaccine for emergency use CDC: Variant COVID-19 strain likely circulating in many states
